The earnings call highlighted strong revenue and net profit growth, with significant achievements across product lines and a successful acquisition. However, challenges remain in maintaining growth and managing costs and margins going into the second half of the year.

Company Guidance

During the Medacta First Half 2025 Results Conference Call, CEO Francesco Siccardi and CFO Corrado Farsetta provided detailed guidance, highlighting a strong H1 revenue of EUR 344.1 million, marking a 19.8% increase in constant currency. The adjusted EBITDA margin was reported at 29.6%, an improvement from the previous year's 26.9%, with net profit reaching EUR 60 million, up 58% from H1 2024. Medacta confirmed a full-year revenue growth target of 16% to 18% in constant currency, with an adjusted EBITDA margin of about 28%. The company's strategic focus on innovation, personalized medical education, and geographic expansion, including potential U.S. manufacturing, were emphasized as key growth drivers. Additionally, Medacta's acquisition of Parcus was noted for its positive impact, including a net one-off gain of EUR 12 million. The company plans to maintain its above-market growth trajectory, aiming for a midterm revenue CAGR of 10% to 14% through 2027.

Strong Revenue Growth

First half 2025 revenues reached EUR 344.1 million, marking an increase of 19.8% in constant currency.

Significant Increase in Net Profit

Net profit for the first half amounted to EUR 60 million, a substantial increase of 58% over H1 2024.

Above-Market Growth in Product Lines

Product lines such as Hip, Knees, Extremities, and Spine showed strong growth, with Extremities growing 44% year-over-year.

Expansion in EBITDA Margin

Adjusted EBITDA margin for H1 reached 29.6% in constant currency, rising 27.5% over the previous year.

Successful Parcus Acquisition

The acquisition of Parcus contributed positively to the financials, reflected in an adjusted reported EBITDA with a positive net one-off of EUR 12 million.

Medacta Group SA (CH:MOVE) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

Daily Earnings Calendar >

CH:MOVE Earnings History

Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change	Slides	Play Transcript
Mar 12, 2026	2025 (Q4)	- / -	1.653	―	―	―
Sep 08, 2025	2025 (Q2)	- / 2.84	1.833	54.77% (+1.00)
Mar 25, 2025	2024 (Q4)	- / 1.65	0.876	88.70% (+0.78)
Sep 25, 2024	2024 (Q2)	- / 1.83	1.439	27.38% (+0.39)
Mar 13, 2024	2023 (Q4)	- / 0.88	1.01	-13.27% (-0.13)
Sep 22, 2023	2023 (Q2)	- / 1.44	1.323	8.77% (+0.12)
Mar 17, 2023	2022 (Q4)	- / 1.01	1.164	-13.23% (-0.15)
Sep 09, 2022	2022 (Q2)	- / 1.32	1.628	-18.73% (-0.30)	―	―
Mar 11, 2022	2021 (Q4)	- / 1.16	1.475	-21.08% (-0.31)	―	―

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat

Missed

CH:MOVE Earnings-Related Price Changes

Report Date	Price 1 Day Before	Price 1 Day After	Percentage Change
Sep 08, 2025	CHF142.40	CHF147.20	+3.37%
Mar 25, 2025	CHF126.77	CHF133.14	+5.02%
Sep 25, 2024	CHF118.21	CHF122.59	+3.70%
Mar 13, 2024	CHF124.78	CHF124.19	-0.48%

Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.

FAQ

When does Medacta Group SA (CH:MOVE) report earnings?

Medacta Group SA (CH:MOVE) is schdueled to report earning on Mar 12, 2026, TBA (Confirmed).

What is Medacta Group SA (CH:MOVE) earnings time?

Medacta Group SA (CH:MOVE) earnings time is at Mar 12, 2026, TBA (Confirmed).

Where can I see when companies are reporting earnings?

You can see which companies are reporting today on our designated earnings calendar.

What companies are reporting earnings today?

You can see a list of the companies which are reporting today on TipRanks earnings calendar.

What is the P/E ratio of Medacta Group SA stock?

The P/E ratio of Medacta Group SA is N/A.

What is CH:MOVE EPS forecast?

Currently, no data Available

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing